- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01375530
Screening af frivillige til kliniske forsøg
VRC 500: Screening af frivillige til kliniske forsøg med undersøgelsesprodukter og licenserede produkter vurderet til forskningsformål
Background:
- The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health needs healthy volunteers for vaccine clinical trials. This is a screening study that is used to identify healthy volunteers who may be eligible to participate in other clinical trials at the Vaccine Research Center that evaluate investigational vaccines, monoclonal antibodies, and injection devices. The VRC conducts studies that will allow researchers to better understand the immune system and how vaccines and monoclonal antibodies work.
Objectives:
- To screen healthy volunteers for clinical trials at the NIAID VRC.
Eligibility:
- Healthy people between 18 and 60 years of age. They must be available to take part in clinical trials and be able to provide blood for research studies.
Design:
- Screening for healthy volunteers to participate in clinical trials is an ongoing process.
- Volunteers will be asked about their medical history, including sexual activity and drug use, and a detailed physical exam will be performed.
- Blood and urine samples may be collected, and possibly other tests as needed to evaluate the volunteer's health status.
- Volunteers will not receive any investigational product in this screening protocol.
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
The purpose of this study is to recruit and screen potential study subjects, mostly healthy volunteers, to determine if they are eligible for clinical trials of investigational products. This screening study also aims to characterize and analyze demographic information as well as laboratory and other medical findings in terms of how they may affect the eligibility of subjects for specific early phase clinical trials. All work will be conducted by the VRC Clinic of the National Institutes of Health or other IRB-approved sites that are collaborating with NIAID/VRC. Educational and recruitment materials on the investigational products and protocols will be
reviewed with and provided to subjects during participation in the screening protocol.
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: VRC Recruitment
- Telefonnummer: (866) 833-5433
- E-mail: vrcrecruitment@mail.nih.gov
Studiesteder
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater, 30030
- Afsluttet
- Emory University
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21201-1595
- Aktiv, ikke rekrutterende
- Univ of MD School of Medicine Center for Vaccine Development & Global Health
-
Bethesda, Maryland, Forenede Stater, 20892
- Rekruttering
- National Institutes of Health Clinical Center
-
Kontakt:
- VRC Clinic
- Telefonnummer: 301-451-8715
- E-mail: vaccines@nih.gov
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Forenede Stater, 19104-6056
- Afsluttet
- University of Pennsylvania-UPenn
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Healthy volunteers
Beskrivelse
- INCLUSION CRITERIA:
Age: 18 years of age or older
Able and willing to complete the informed consent process
Agree to have blood and/or tissue samples collected and stored for future studies of investigational products, the immune system, and/or other medical conditions
EXCLUSION CRITERIA:
A condition in which repeated blood draws or injections pose more than minimal risk for the subject such as hemophilia, other severe coagulation disorders or significantly impaired venous access
A condition that requires active medical intervention or monitoring to avert serious danger to the participant s health or well-being
Known to be pregnant or breast-feeding
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: OTHER
- Tidsperspektiver: OTHER
Kohorter og interventioner
Gruppe / kohorte |
|---|
|
1
Healthy adults 18 - 60 years old |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
To screen subjects for their eligibility to participate in clinical trials.
Tidsramme: Ongoing
|
Duration of subject participation is variable, and may last from a few weeks to several months for each subject. |
Ongoing
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Lasonji A Holman, C.R.N.P., National Institute of Allergy and Infectious Diseases (NIAID)
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Anslået)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- 110164
- 11-I-0164
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .